Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status
Phipatanakul W, Papadopoulos NG, Hernandez-Trujillo V, Hamelmann E, Zeiger RS, Ducharme FM, Jain N, Xia C, Gall R, Pandit-Abid N, Siddiqui S, et al. (2023)
In: Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022., 78. Hoboken: Wiley: 5-6.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Phipatanakul, W.;
Papadopoulos, N. G.;
Hernandez-Trujillo, V.;
Hamelmann, EckardUniBi;
Zeiger, R. S.;
Ducharme, F. M.;
Jain, N.;
Xia, C.;
Gall, R.;
Pandit-Abid, N.;
Siddiqui, S.;
Jacob-Nara, J. A.
Alle
Alle
Erscheinungsjahr
2023
Titel des Konferenzbandes
Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022
Band
78
Seite(n)
5-6
Konferenz
Annual European-Academy-of-Allergy-and-Clinical-Immunology Hybrid Congress (EAACI)
Konferenzort
Prague, CZECH REPUBLIC
Konferenzdatum
2022-07-01 – 2022-07-03
ISSN
0105-4538
eISSN
1398-9995
Page URI
https://pub.uni-bielefeld.de/record/2985888
Zitieren
Phipatanakul W, Papadopoulos NG, Hernandez-Trujillo V, et al. Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status. In: Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Vol 78. Hoboken: Wiley; 2023: 5-6.
Phipatanakul, W., Papadopoulos, N. G., Hernandez-Trujillo, V., Hamelmann, E., Zeiger, R. S., Ducharme, F. M., Jain, N., et al. (2023). Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, 78, 5-6. Hoboken: Wiley. https://doi.org/10.1111/all.15614
Phipatanakul, W., Papadopoulos, N. G., Hernandez-Trujillo, V., Hamelmann, Eckard, Zeiger, R. S., Ducharme, F. M., Jain, N., et al. 2023. “Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status”. In Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, 78:5-6. Hoboken: Wiley.
Phipatanakul, W., Papadopoulos, N. G., Hernandez-Trujillo, V., Hamelmann, E., Zeiger, R. S., Ducharme, F. M., Jain, N., Xia, C., Gall, R., Pandit-Abid, N., et al. (2023). “Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status” in Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, vol. 78, (Hoboken: Wiley), 5-6.
Phipatanakul, W., et al., 2023. Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status. In Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. no.78 Hoboken: Wiley, pp. 5-6.
W. Phipatanakul, et al., “Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status”, Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022, vol. 78, Hoboken: Wiley, 2023, pp.5-6.
Phipatanakul, W., Papadopoulos, N.G., Hernandez-Trujillo, V., Hamelmann, E., Zeiger, R.S., Ducharme, F.M., Jain, N., Xia, C., Gall, R., Pandit-Abid, N., Siddiqui, S., Jacob-Nara, J.A., Rowe, P.J., Deniz, Y.: Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. 78, p. 5-6. Wiley, Hoboken (2023).
Phipatanakul, W., Papadopoulos, N. G., Hernandez-Trujillo, V., Hamelmann, Eckard, Zeiger, R. S., Ducharme, F. M., Jain, N., Xia, C., Gall, R., Pandit-Abid, N., Siddiqui, S., Jacob-Nara, J. A., Rowe, P. J., and Deniz, Y. “Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to- severe type 2 inflammatory asthma by allergen sensitization status”. Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 1-3 July 2022. Hoboken: Wiley, 2023.Vol. 78. 5-6.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar